Testing effectiveness (Phase 2)Study completedNCT00896077
What this trial is testing
Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes
Who this might be right for
HealthyType 1 Diabetes
DiaKine Therapeutics, Inc. 8